Inozyme Pharma Inc (INZY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Operating Expenses | 104,030 | 75,645 | 68,675 | 56,646 | 57,041 |
| Operating Income | -104,030 | -75,645 | -68,675 | -56,646 | -57,041 |
| Interest Expense | 5,558 | 3,333 | 262 | 0 | 0 |
| Other Income | 7,564 | 7,809 | 1,876 | 22 | 617 |
| Pre-tax Income | -102,024 | -71,169 | -67,061 | -56,624 | -56,424 |
| Net Income Continuous | -102,024 | -71,169 | -67,061 | -56,624 | -56,424 |
| Net Income | $-102,024 | $-71,169 | $-67,061 | $-56,624 | $-56,424 |
| EPS Basic Total Ops | -1.62 | -1.37 | -1.78 | -2.40 | -5.11 |
| EPS Basic Continuous Ops | -1.62 | -1.37 | -1.78 | -2.40 | -5.11 |
| EPS Diluted Total Ops | -1.62 | -1.37 | -1.78 | -2.40 | -5.11 |
| EPS Diluted Continuous Ops | -1.62 | -1.37 | -1.78 | -2.40 | -5.11 |
| EPS Diluted Before Non-Recurring Items | -1.62 | -1.37 | -1.78 | -2.40 | -5.11 |
| EBITDA(a) | $-108,327 | $-80,250 | $-69,602 | $-55,802 | $-56,547 |